Aarey Drugs & Pharmaceuticals Ltd

₹ 78.0 0.49%

17 Jun 10:49 a.m.

aareydrugs.com BSE: 524412 NSE: AAREYDRUGS

About

Incorporated in 1990, Aarey Drugs & Pharmaceuticals Ltd is a manufacturer of API / Bulk Drugs and offers products for diverse
industrial applications^[1]

Key Points

Business Overview:^[1]
ADPL does manufacturing of active pharmaceutical ingredients, intermediates, specialty chemicals, and trading of industrial solvents & chemicals. It caters to pharmaceuticals formulation manufacturers and pharmaceutical merchant exports.

Website BSE NSE - BE

Market Cap ₹ 221 Cr.
Current Price ₹ 78.0
High / Low ₹ 100 / 50.3
Stock P/E 55.7
Book Value ₹ 53.0
Dividend Yield 0.00 %
ROCE 5.58 %
ROE 2.75 %
Face Value ₹ 10.0

Add ratio to table

Edit ratios

Pros

Company is expected to give good quarter

Cons

Though the company is reporting repeated profits, it is not paying out dividend
Promoter holding has decreased over last quarter: -1.35%
The company has delivered a poor sales growth of 6.27% over past five years.
Promoter holding is low: 37.7%
Company has a low return on equity of 3.13% over last 3 years.
Earnings include an other income of Rs.6.10 Cr.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns

Loading peers table ...

Detailed Comparison with:

Quarterly Results

Figures in Rs. Crores

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
	162.88	50.96	57.83	76.48	210.35	126.91	105.14	133.79	108.10	102.21	84.16	96.43	189.47
	160.36	49.62	55.99	73.78	211.79	125.73	101.42	131.59	112.31	100.50	81.52	97.94	185.13
Operating Profit	2.52	1.34	1.84	2.70	-1.44	1.18	3.72	2.20	-4.21	1.71	2.64	-1.51	4.34
OPM %	1.55%	2.63%	3.18%	3.53%	-0.68%	0.93%	3.54%	1.64%	-3.89%	1.67%	3.14%	-1.57%	2.29%
	0.84	0.70	0.84	0.29	5.14	1.58	0.02	0.68	7.54	1.55	0.79	4.18	-0.43
Interest	0.20	0.42	0.41	0.47	0.40	0.96	0.49	0.58	1.30	1.04	1.26	0.92	1.78
Depreciation	1.02	0.89	1.27	1.06	1.15	0.47	1.51	0.90	0.41	0.49	0.69	0.83	0.85
Profit before tax	2.14	0.73	1.00	1.46	2.15	1.33	1.74	1.40	1.62	1.73	1.48	0.92	1.28
Tax %	83.18%	0.00%	-22.00%	30.14%	-0.47%	6.77%	8.62%	48.57%	71.60%	20.81%	31.08%	38.04%	-21.88%
	0.36	0.72	1.23	1.02	2.15	1.24	1.60	0.72	0.47	1.37	1.02	0.57	1.56
EPS in Rs	0.14	0.28	0.48	0.40	0.77	0.44	0.57	0.25	0.17	0.48	0.36	0.20	0.55
Raw PDF

Profit & Loss

Figures in Rs. Crores

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	213	246	396	349	354	298	348	493	419	396	474	472
	212	245	386	342	347	294	344	481	411	391	471	465
Operating Profit	1	1	10	8	8	3	5	11	8	4	3	7
OPM %	1%	0%	2%	2%	2%	1%	1%	2%	2%	1%	1%	2%
	3	3	3	3	4	7	7	3	3	7	10	6
Interest	1	2	4	2	2	2	2	2	3	4	5	5
Depreciation	1	1	1	1	1	1	1	2	2	2	2	3
Profit before tax	1	2	8	8	9	7	8	10	6	5	6	5
Tax %	23%	29%	31%	25%	27%	20%	21%	35%	37%	12%	34%	27%
	1	1	5	6	7	6	7	7	4	5	4	4
EPS in Rs	0.65	0.77	3.02	2.64	2.80	2.48	2.78	2.58	1.49	1.67	1.42	1.40
Dividend Payout %	0%	0%	0%	0%	4%	0%	0%	0%	0%	0%	0%	0%

Compounded Sales Growth
10 Years:	7%
5 Years:	6%
3 Years:	4%
TTM:	0%

Compounded Profit Growth
10 Years:	12%
5 Years:	-9%
3 Years:	2%
TTM:	-1%

Stock Price CAGR
10 Years:	4%
5 Years:	19%
3 Years:	33%
1 Year:	40%

Return on Equity
10 Years:	5%
5 Years:	4%
3 Years:	3%
Last Year:	3%

Balance Sheet

Figures in Rs. Crores

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	17	17	18	23	23	23	23	25	25	28	28	28
Reserves	19	20	31	57	63	69	75	88	92	105	110	122
	11	15	10	3	16	18	18	14	38	31	35	50
	69	74	83	86	43	84	116	117	136	139	117	97
Total Liabilities	115	125	142	170	146	194	233	245	291	303	291	297
	6	8	12	12	12	12	14	14	14	13	16	26
CWIP	0	0	0	0	0	0	0	0	0	0	0	0
Investments	0	0	0	0	0	0	0	0	0	1	2	2
	109	117	130	157	133	181	218	230	277	289	272	269
Total Assets	115	125	142	170	146	194	233	245	291	303	291	297

Cash Flows

Figures in Rs. Crores

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	3	6	1	-20	1	3	5	0	-1	-3	10	10
	-2	-3	-5	-1	-1	-1	-3	-3	0	-2	-6	-12
	-2	-2	4	23	-2	-2	-2	2	1	6	-4	2
Net Cash Flow	-1	1	-1	2	-3	0	0	-0	1	1	-0	-0
Free Cash Flow	1	3	-4	-21	-1	2	3	-2	-2	-4	5	-2
CFO/OP	239%	560%	28%	-232%	37%	135%	154%	36%	13%	-37%	421%	164%

Ratios

Figures in Rs. Crores

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	114	108	75	100	109	118	170	101	165	170	103	100
Inventory Days	7	3	5	16	23	21	20	11	26	33	36	33
Days Payable	117	108	71	84	40	98	120	86	115	123	81	66
Cash Conversion Cycle	5	3	9	32	92	42	69	26	76	80	58	68
Working Capital Days	49	40	34	69	77	99	91	68	89	106	89	90
ROCE %	7%	7%	22%	14%	12%	8%	9%	10%	6%	6%	6%	6%

Insights

In beta

Mar 2014

Mar 2015

Mar 2016

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Coal Consumption
Metric Tons (MT)

xxx.xx	x.xx	x.xx	xx.xx	x.xx	x.xx	x.xx	xxx.xx	xxx.xx	xxx.xx	x.xx	xxx.xx
xxx,xxx.xx	xxx,xxx.xx	x,xxx.xx	x,xxx,xxx.xx	xxx,xxx.xx	xxx,xxx.xx	xxx,xxx.xx	xxx,xxx.xx	xxx,xxx.xx	xxx,xxx.xx	xxx,xxx.xx	xxx,xxx.xx
x	x	x	x	x	x	x	x	x	x	xxx,xxx	xx,xxx,xxx
x.xx	x.xx	x.xx	x.xx	xxx.xx	xxx.xx	xxx.xx	xxx.xx	xxx.xx	xxx.xx	xxx.xx	x,xxx.xx
			xx.xx	xxx.xx				xx.xx	xxx.xx	xxx.xx	x,xxx.xx

Please log in to see hidden values.

Electricity Consumption
KWH

R&D Capital Expenditure
INR

Total Production Volume
Metric Tons (MT)

Biomass Briquette Consumption
Metric Tons (MT)

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

1 Recently

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
	50.04%	50.04%	50.04%	45.28%	45.28%	45.44%	44.80%	44.80%	44.80%	44.80%	39.05%	37.71%
	3.92%	3.94%	3.83%	3.40%	3.40%	2.75%	2.34%	2.34%	1.97%	1.13%	3.86%	4.18%
	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	1.62%
	46.03%	46.01%	46.12%	51.31%	51.32%	51.81%	52.86%	52.86%	53.23%	54.07%	57.09%	56.49%
No. of Shareholders	17,538	16,086	15,269	16,843	16,179	16,676	16,288	16,257	15,796	14,897	14,063	14,188

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	53.40%	49.86%	50.44%	49.38%	49.38%	48.06%	50.05%	45.28%	44.80%	37.71%
	0.00%	0.27%	15.04%	14.34%	7.12%	4.23%	3.92%	3.40%	2.34%	4.18%
	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	1.62%
	46.60%	49.88%	34.52%	36.28%	43.50%	47.70%	46.04%	51.31%	52.86%	56.49%
No. of Shareholders	7,083	8,314	8,122	7,952	10,688	17,565	17,699	16,843	16,257	14,188

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Aarey Drugs & Pharmaceuticals Ltd

Aarey Drugs & Pharmaceuticals Ltd

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flows

Ratios

Insights

Shareholding Pattern

Documents

Announcements

Annual reports

Credit ratings